Optic Neuritis Treatment Market - Top Companies and Manufacturers

  • Report ID: 4174
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Optic Neuritis Treatment Landscape

    • Santen Pharmaceutical Co., Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Mallinckrodt plc
    • AbbVie Inc.
    • Novartis AG
    • Sanofi-aventis Groupe
    • AdvoCare International
    • Hikma Pharmaceuticals PLC
    • Henry Schein, Inc.
    • Fresenius Kabi USA
    • Pfizer Inc.

     


Browse Key Market Insights with Data Illustration:

In the News

  • Novartis AC to acquire European Commission Approval for Tabrecta, lapatinib, to cure small cell lung cancer. Tabrecta also provides specialized therapy for cured patients living with NSCLC.
  • Hikma Pharmaceuticals PLC to announce to completion of the acquisition of Custopharm Inc. The company is acquired from Water Street Healthcare Partners by getting approval from the US Federal Trade Commission.

Author Credits:  Radhika Pawar


  • Report ID: 4174
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of optic neuritis treatment is assessed at USD 243.59 Million.

The optic neuritis treatment market size was over USD 232.1 Million in 2023 and is poised to reach USD 465.54 Million by the end of 2036, growing at around 5.5% CAGR during the forecast period i.e., between 2024-2036. Rising incidences of bacterial infections across the globe and the significant increment in global geriatric population are the major factors driving the growth of the market.

North America is predicted to account for the largest share of 35% by 2036, impelled by higher adoption of steroids in the region.

Santen Pharmaceutical Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi-aventis Groupe, AdvoCare International, Hikma Pharmaceuticals PLC, Henry Schein, Inc., Fresenius Kabi USA, Pfizer Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample